Literature DB >> 30312805

Does Obesity Increase Respiratory Tract Infections in Patients with Asthma?

Monica Tang1, Robert J Henderson2, Janet T Holbrook2, Loretta G Que3, Anne M Mathews3, Robert A Wise4, Anne E Dixon5, Stephen P Peters6, Linda Rogers7, Lewis J Smith8, W Gerald Teague9, Jason E Lang10.   

Abstract

BACKGROUND: Because respiratory tract infections (RTIs) precede most exacerbations, a better understanding of the risk factors of RTIs and RTI-associated exacerbations in patients with asthma is a pressing public health need. Obesity in patients with asthma is associated with worse asthma control and higher asthma-associated health care utilization, but its effect on RTI risk is unknown.
OBJECTIVE: We aimed to study the association of body mass index (BMI) classification on the risk of self-reported RTIs and related asthma morbidity among adults and children with asthma.
METHODS: This post hoc analysis of 5 large asthma trials involving 747 children and 1287 adults compared BMI classification, defined as lean, overweight, and obese based on age-appropriate BMI and BMI-percentile conventions. The primary outcome was rate of visits with RTIs. Secondary asthma outcomes included upper respiratory infection (URI) severity, systemic steroid use, and health care contact.
RESULTS: Children had 1.4 times the rate of RTI compared with adults (95% confidence interval 1.27-1.56). In all participants, BMI classification did not affect the rate of visits with RTI. In children, BMI classification did not affect URI severity, all-cause asthma events, or RTI-associated asthma events. However, in adults, higher BMI classification was associated with an increase in moderate/severe URI (P = .02). Adults with higher BMI classification also had increased rates of all-cause and RTI-associated asthma exacerbations requiring systemic steroids and health care contact.
CONCLUSIONS: BMI classification was not associated with an increased risk of RTIs in children or adults. In adults only, obesity was associated with increased URI severity and all-cause and RTI-associated asthma morbidity.
Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; Obesity; Respiratory tract infections

Year:  2018        PMID: 30312805      PMCID: PMC6609096          DOI: 10.1016/j.jaip.2018.09.033

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  38 in total

Review 1.  Obesity and infection.

Authors:  Matthew E Falagas; Maria Kompoti
Journal:  Lancet Infect Dis       Date:  2006-07       Impact factor: 25.071

2.  Efficacy of esomeprazole for treatment of poorly controlled asthma.

Authors:  John G Mastronarde; Nicholas R Anthonisen; Mario Castro; Janet T Holbrook; Frank T Leone; W Gerald Teague; Robert A Wise
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

3.  A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women.

Authors:  I Baik; G C Curhan; E B Rimm; A Bendich; W C Willett; W W Fawzi
Journal:  Arch Intern Med       Date:  2000-11-13

4.  Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study.

Authors:  Jonathan M Corne; Clare Marshall; Sandra Smith; Jacquie Schreiber; Gwendolyn Sanderson; Stephen T Holgate; Sebastian L Johnston
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

5.  Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.

Authors:  Roberto Berni Canani; Pia Cirillo; Paola Roggero; Claudio Romano; Basilio Malamisura; Gianluca Terrin; Annalisa Passariello; Francesco Manguso; Lorenzo Morelli; Alfredo Guarino
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

6.  Comparison of anthropometric measures of obesity in childhood allergic asthma: central obesity is most relevant.

Authors:  Salma M A Musaad; Tia Patterson; Mark Ericksen; Mark Lindsey; Kim Dietrich; Paul Succop; Gurjit K Khurana Hershey
Journal:  J Allergy Clin Immunol       Date:  2009-05-12       Impact factor: 10.793

7.  Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245.

Authors:  J H Wandall
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

8.  Randomized comparison of strategies for reducing treatment in mild persistent asthma.

Authors:  Stephen P Peters; Nicholas Anthonisen; Mario Castro; Janet T Holbrook; Charles G Irvin; Lewis J Smith; Robert A Wise
Journal:  N Engl J Med       Date:  2007-05-17       Impact factor: 91.245

Review 9.  Effect of aging on respiratory system physiology and immunology.

Authors:  Gulshan Sharma; James Goodwin
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

Review 10.  Viruses as precipitants of asthma symptoms. II. Physiology and mechanisms.

Authors:  P G Bardin; S L Johnston; P K Pattemore
Journal:  Clin Exp Allergy       Date:  1992-09       Impact factor: 5.018

View more
  3 in total

1.  Obesity Is Associated with Sustained Symptomatology and Unique Inflammatory Features in Children with Asthma.

Authors:  Anne M Fitzpatrick; Abby D Mutic; Ahmad F Mohammad; Susan T Stephenson; Jocelyn R Grunwell
Journal:  J Allergy Clin Immunol Pract       Date:  2021-10-22

2.  Altered gut microbiome compositions are associated with the severity of asthma.

Authors:  Zhiqiang Wang; Zhengdao Lai; Xiaoxian Zhang; Peikai Huang; Jiaxing Xie; Qian Jiang; Qingling Zhang; Kian Fan Chung
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 2.895

3.  Obesity Does Not Increase the Risk of Asthma Readmissions.

Authors:  Francisco-Javier Gonzalez-Barcala; Juan-José Nieto-Fontarigo; Tamara Lourido-Cebreiro; Carlota Rodríguez-García; Maria-Esther San-Jose; Jose-Martín Carreira; Uxio Calvo-Alvarez; Maria-Jesus Cruz; David Facal; Maria-Teresa Garcia-Sanz; Luis Valdes-Cuadrado; Francisco-Javier Salgado
Journal:  J Clin Med       Date:  2020-01-14       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.